IMMU-24. IMMUNOTHERAPEUTIC NANOTECHNOLOGY TARGETING IDO1 FOR PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA

BACKGROUND: Research on adult high-grade gliomas has shown a targetable pathway through the inflammation-induced expression of indoleamine 2,3 dioxygenase (IDO1) and its recognized ability to suppress the anti-tumor immune response. Our project delineates the role of indoleamine 2,3 dioxygenase 1 (I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Lenzen, Alicia, Cole, Lisa, Lauing, Kristen L, Zhai, Lijie, Ladomersky, Erik, Lulla, Rishi R, Hashizume, Rintaro, Stegh, Alexander, Wainwright, Derek A
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012849/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.340
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars